Skip to main content
TipRanks
Go Ultimate75% OFF

Opus Genetics (R3X1) Financial Statements

3 Followers

Opus Genetics Financial Overview

Opus Genetics's market cap is currently $349.00M. The company's EPS TTM is $-1.53; its P/E ratio is -2.60; Opus Genetics is estimated to report earnings on March 11, 2027, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 14.20M$ 10.99M$ 19.05M$ 39.85M$ 589.00K
Gross Profit$ 14.20M$ 10.99M$ 19.05M$ 39.85M$ 589.00K
Operating Income$ -38.60M$ -62.07M$ -10.56M$ 18.23M$ -22.70M
EBITDA$ -48.07M$ -57.52M$ -9.97M$ 18.22M$ -56.69M
Net Income$ -49.59M$ -57.53M$ -9.99M$ 17.89M$ -56.69M
Balance Sheet
Cash & Short-Term Investments$ 45.09M$ 30.32M$ 50.52M$ 42.68M$ 24.75M
Total Assets$ 50.24M$ 36.86M$ 53.95M$ 48.99M$ 26.08M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 538.00K
Net Debt$ -45.09M$ -30.32M$ -50.50M$ -42.63M$ -24.00M
Total Liabilities$ 34.90M$ 30.14M$ 4.04M$ 2.75M$ 3.85M
Stockholders' Equity$ 15.35M$ 6.72M$ 49.91M$ 46.24M$ 22.22M
Cash Flow
Free Cash Flow$ -35.25M$ -25.58M$ -1.11M$ 14.31M$ -19.37M
Operating Cash Flow$ -35.25M$ -25.58M$ -1.11M$ 14.31M$ -19.37M
Investing Cash Flow$ 0.00$ 1.21M$ 0.00$ 0.00$ -100.00K
Financing Cash Flow$ 50.02M$ 4.19M$ 8.98M$ 3.79M$ 27.61M

Currency in USD

Opus Genetics Earnings and Revenue History

-100M-50M050M-12000 %-6000 %0 %6000 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin

Opus Genetics Liabilities to Assets

020M40M60M0 %200 %400 %600 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Opus Genetics Cash Flow

-40M-20M020M40M60M2019202020212022202320242025OperatingInvestingFinancing

Opus Genetics Forecast EPS vs Actual EPS

-0.8-0.6-0.4-0.20Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss